The First Bay Area Medical Co-Creation Conference (BAMCIC), focusing on the "Bay Area Medical Co-Creation Center"(BAMCIC), will be held in Beijing, China, from September 30th to September 30th, 2012, with a focus on the "Bay Area Medical Co-Creation Center"(BAMCIC). BAMCIC"), focusing on "Digital Intelligent Pharmaceuticals", invites representatives of domestic and foreign digital transformation enterprises and famous service providers to gather in Shenzhen, the leading city of BT+IT technology integration, and focus on "Digital Intelligent Pharmaceuticals". AI-driven R&D, system selection strategy, digital factory, automation strategy and other cutting-edge topics. Factory, automation strategy and other cutting-edge topics, core technologies and key points of digital transformation and upgradingfor in-depth exchanges and discussions, to provide the industry with pharmaceutical digital intelligence transformation of practical experience and skills, to help the industry high-quality development.
Conference Information
Guidance Unit| Shenzhen Municipal Development and Reform Commission, Shenzhen Municipal Market Supervision Administration, Shenzhen Nanshan District People's Government

Organizer| Shenzhen Nanshan District Bureau of Science and Technology Innovation, Shenzhen Nanshan District Bureau of Health and Wellness, Shenzhen Branch of China General Research Institute of Pharmaceutical Industry, Nanshan DistrictJoint Party Committee of Incubation Carriers of "House of Entrepreneurship"

Organizers | Shenzhen Nanshan District Innovation Development Promotion Center, Dandelion, Huawei Cloud Computing Technology Company Limited, Shenzhen Jingtai Technology Company Limited, Shenzhen Yinosi Biomedical Safety Evaluation Research Institute Company Limited, Shenzhen Biomedical Industry Alliance

Supporting Organizations | Shenzhen Esky Purify Technology Company Limited, Suzhou Guinea Pig Technology Company Limited

Activity Time| December 8-9, 2023Location of the event| Innovation Parlor on the first floor of Nanshan Digital Culture Industry BaseEvent Size| 200 people

Conference Agenda

Main Forum

2023/12/< 8 09:00-17:30

09:00-09:15

Guest Speech

09:15-09:35

Bioeconomy and New Opportunities for Cancer Treatment' lt;/span>

Chen Youhai

Dean, Chair Professor, School of Pharmacy, Shenzhen Polytechnic University

Member of the European Academy of Sciences

09:35-09:50

Nanshan District"House of Entrepreneurship"Party Committee Unveiling Ceremony

Signing Ceremony

Reading the initiative

09:50-10:10

Teabreak

10:10-10:30

Application and Prospect of Digital Intelligence Innovation in Biomedical Industry

horseKen

Co-founder and Chief Executive Officer of Shenzhen Jintai Technology Co.

10:30-10:50

Huawei CloudAIPharmaceutical Platform Boosts R&D Innovation for Pharmaceutical Companies

JoeNan

Chief Scientist, Director of Healthcare Products, Huawei Cloud Healthcare

10:50-11:10

Innovative Drugs in the U.S. and China Dual-reporting Non-clinical Evaluation Reporting Points

RegularColorful

President of Shanghai Enos Bio-Tech Co.

11:10-11:30

RNATherapeutics:current trends and perspectives

MaArashi

Vice Dean of Shenzhen International Graduate School of Tsinghua University

11:30-14:00

NoonHoliday

14:00-14:30

China's Innovative Drug Industry Investment Opportunities and Challenges

< span style="font-family:Calibri;font-size:16px"><<

Chairman of Guangdong Small Molecule New Drug Innovation Center

14:30-15:00

All Human SourceVH Single Domain Antibody Development Platform

Liu Xianglei

Shanghai Institute of Pharmaceutical Industry

15:00-15:30

Industry4.0, the newest and most advanced technology in the world. quot;>, how digital clean technology can empower pharmaceutical companies to explore the value chain

Xia Qunyan

General Manager of Shenzhen Esky Purify Technology Co.

15:30-15:40

TeaHiatus

15:40-16:10

Celitec's Digital Transformation Practices

Ma Yonggang

Shenzhen Xinlitai Pharmaceutical ProcessITManagement Department Information Director

16:10-16:30

AINew Exploration of Digital Marketing Transformation for Kanzhe Pharmaceutical

KingKui

Shenzhen Kang Zhe Director of Informatization, Shenzhen Kangzhe Information Technology Co. padding:0 0 0 0 0;line-height:28px">

16:30-17:30

Roundtable Dialogue:Opportunities and Challenges for Innovative Drug Development in China

主持人:

HorseKen Co-founder and CEO of Shenzhen Jintai Technology Co.

JiaBin:

YuanMing Founder &Chairman of Shenzhen Huayu Kangming Biomedical Co. span>

KuoSen Research Fellow at SZCIC's Institute of Innovative Investment

YuMeng Deputy General Manager of Shenzhen Jun Shengtai Biotechnology Co. style="margin-bottom:16px;text-align:left;">
Subforum Details